NSEInvestor Presentation21 Aug 2026 · 21 Aug 2026, 02:59 pm
Investor Presentation
Valiant Organics Limited · VALIANTORG
✦ AI SummaryResults
Valiant Organics Limited has informed the Exchange about Investor Presentation for the quarter ended June 30, 2026, with a copy hosted on the company's website.
Analysis Scores
Earnings Impact8/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk6/10
Liquidity Impact9/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Valiant Organics Limited has informed the Exchange about Investor Presentation
Attachments (1)
📄pdf
Download →
VALIANTORG_21082026145906_Intimation_IP_June_2026.pdf
View document text
August 21, 2026
To, To,
Listing / Compliance Department Listing / Compliance Department
BSE LTD National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1,
Dalal Street G Block Bandra-Kurla Complex,
Mumbai- 400 001 Bandra (E), Mumbai- 400 051.
SCRIP CODE – 540145 SYMBOL- VALIANTORG
Sub: Investors’ Presentation
Dear Sir / Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, please find enclosed herewith Investors’ Presentation on the financial results of Valiant Organics
Limited (the “Company”) for the quarter ended June 30, 2026.
A copy of aforesaid Investor Presentation is also hosted on the website of Company
www.valiantorganics.com.
Please take the same on your records.
Thanking you,
Yours faithfully,
For Valiant Organics Limited
Kaustubh Kulkarni
Company Secretary
ICSI M. No.: A52980
Encl.: a/a
Regd. Office:109, Udyog Kshetra, 1st Floor, Mulund Goregaon Link Rd, Mulund (W), Mumbai 400 080, Maharashtra, India.
Corporate Office: 701-A, 7th Floor, Tower-B, Embassy 247, L.B.S. Road, Vikhroli (W), Mumbai - 400 083, Maharashtra, India.
+91 22 6797 6683 • info@valiantorganics.com • www.valiantorganics.com
CIN NO.: L24230MH2005PLC151348
Ea rnings Presentation | Q1-FY27
SNAPSHOT
One of the largest chlorophenol One of the leading manufacturer of
derivatives manufacturer globally Benzene derivatives products
One of the largest domestic PNA One of the few commercial players in
manufacturer Ortho Anisidine and Para Anisidine
Diversified client base across
Amongst 1st few domestic PAP
Pharmaceuticals, Dyes & Pigments,
Manufacturers
Agrochemicals and specialty chemicals.
6 Manufacturing units across 5 Locations 5 Zero Liquid Discharge plants
Total Production Capacity of 70,000 TPA 900+ Employees
Company Overview
Valiant Organics Limited was incorporated in 1984 by first generation technocrats and is headquartered out of Mumbai, India.
The company is focused on the manufacturing and marketing of specialty chemicals which find usage in a variety of industries, including agrochemicals,
pharmaceuticals, dyes, pigments, and veterinary medications.
Key chemistries include Chlorination, Hydrogenation, Ammonolysis, Acetylation, Sulphonation, Methoxylation amongst others.
Over the years the company has primarily focused on manufacturing specialty chemicals that have a high demand but low supply and are primarily
dependent on imports.
The company is listed on both the BSE and NSE with a market capitalization of INR ~ 7,545.68 Mn. as on 30th June 2026.
Operating Revenue (INR Mn) and EBITDA Margin (%) FY26 Revenue Break-up – Chemistries FY26 Revenue Break-up – End user Industry
Others, 6%
12000 10,518 50.00%
45.00% Pharmaceuticals;
10000
7,231 7,188 7,388 34 50 .. 00 00 %% Chlorination, Dyes & 21%
8000
30.00% 20% Pigments; 45%
6000 17.97% 25.00% Ammonolysis,
15.62%
11.94% 20.00% 26% Specialty
4000 2,315 15.00%
5.28% 7.47% Chemicals; 10%
2000 10.00% Agro
5.00% Hydrogenation,
Chemicals;
0 0.00% 48%
FY23 FY24 FY25 FY26 Q1-FY27
Revenue EBITDA Margin
*Pursuant to the allotment of further equity shares through IPO by the Company's material step down subsidiary namely, Valiant Laboratories Limited ("VLL"), the stake of Company's subsidiary Dhanvallabh Ventures LLP in VLL has been diluted to 46.83% and accordingly VLL has ceased to be
a step down subsidiary of the Company and has became an associate company w.e.f. October 04,2023. Hence, consolidated financial of previous periods and YTD results are not comparable.
Valiant Organics Limited | Q1-2027 3
Chemistries And Product Basket
Q1-FY27 Revenue Share
Hydrogenation
Ammonolysis
Key Products:
Industries Served:
Key Products: • Ortho Anisidine
Industries Served: • Dyes
• Para Nitro Aniline • Para Anisidine
• Dyes • Pigments
• Ortho Chloro Para Nitro Aniline • IPPCA
• Pigments • Pharmaceutical
• Meta Chloro Aniline
• Agro Chemicals
• Para Amino Phenol
4 21%
• Ortho Amino Phenol
Others
Acetylation Sulphonation Methoxylation 19% Chlorination
Key Products: Key Products: Key Products:
• 6 Acetyl OAPSA • OT5SA • Ortho Nitro Anisole Key Products: Industries Served:
• OA Acetanilide • 4B Acid • Para Nitro Anisole • Para ChloroPhenol (PCP) • Agro Chemicals
• PA Acetanilide • 2B Acid • Ortho ChloroPhenol (OCP) • Cosmetics
6% • 2,4 Di Chlorophenol (2,4 DCP) • Veterinary
Industries Served: Industries Served: Industries Served: • 2,6 Di ChloroPhenol (2,6 DCP) • Pharmaceuticals
• Dyes • Dyes • Dyes • 2,4,6 Tri ChloroPhenol (2,4,6 TCP)
• Pigments • Pigments
Valiant Organics Limited | Q1-2027 4
Manufacturing Footprint
HYDROGENATION & METHOXYLATION-
CHLORINATION – SARIGAM
JHAGADIA UNIT 1
• Capacity: 18,000 MTPA
• Capacity: 28,800 MTPA
• Products: PCP, OCP, 2,4 DCP, 2,6 DCP,
• Products: ONA/OA, PNA/PA, IPPCA,
2,4,6 TCP
CONVERSION PRODUCTS
HYDROGENATION – JHAGADIA UNIT 2
AMMONOLYSIS - VAPI
• Capacity: 12,000 MTPA
• Capacity: 10,000 MTPA
• Products: PAP, PHARMA INTERMEDIATES
• Products: PNA, OCPNA
ACETYLATION & SULPHONATION –
AMMONOLYSIS - TARAPUR AHMEDABAD
• Capacity: 6,600 MTPA • Capacity: 1,800 MTPA
• Products: PNA • Products: 6 ACETYL OAPSA, OA/PA
ACETANILIDE, OT5SA
Valiant Organics Limited | Q1-2027 5
Key Strengths
Domain expertise and broad Plant locations are
process understanding in a Wide supply chain strategically located near
variety of chemistries. The provides the continuous ports to provide a
executive team is made up of availability of adequate competitive advantage,
first-generation technocrats and high-quality raw significant logistical cost
with more than 50 years of materials and savings, and faster
collective expertise. manufacturing. delivery times.
Robust Strong Distinct
Integrated
Business Customer Product
Operations
Model Relations Portfolio
Strategic
Widespread
Domain
Location of
Supply Chain
Knowledge
Plants
Diverse product range
Manufacturing a diverse
Multi-use and backward Established multi-year
and client base across
range of intermediates
integrated plants to relationships with clients in
numerous industries and
as well as value-added
produce a wide range of both domestic and
countries provides a
products for a variety of
products and tailor them to international markets due to
sustainable business
industries.
meet the diverse needs, high-quality standards,
model in multiple
technical qualifications, innovative production
chemistries by lowering
batch sizes, and delivery capabilities.
product, industry, and
schedules of our clients.
geographical risk.
Valiant Organics Limited | Q1-2027 6
Q1-FY27 HIGHLIGHTS
Valiant Organics Limited | Q1-2027 7
Q1-FY27 CONSOLIDATED FINANCIAL HIGHLIGHTS
INR 2,315 Mn
Operational Revenue
INR 416 Mn
Operating EBITDA
17.97%
Operating EBITDA Margin
INR 293 Mn
Profit After Tax
12.66%
PAT Margin
INR 10.44/ Share
Valiant Organics Limited | Q1-2027 8
Q1-FY27 Operational Highlights
Q1-FY27 Revenue Break-up – Chemistries
• Total Revenue grew 14% YoY to INR 2,342 million, marking the highest quarterly revenue
Others, 6%
in the last six quarters and a full recovery from the H1 FY26 trough.
• Gross Profit Margin improved to 43% from 39% YoY, supported by a ~410 bps reduction Chlorination,
in raw material consumption.
Ammonolysis,
• Raw Material Cost declined to 57% of sales from 61%, generating savings of ~INR 4 for 21%
every INR 100 of revenue. Hydrogenation,
• EBITDA margin expanded to 17.97%, the highest in the last six quarters, supported by
operating leverage.
• Employee and other expenses increased only 4.6% YoY, despite 14% revenue growth,
Q1-FY27 Volume Break-up – Chemistries
reflecting improved operating efficiency.
Others, 5%
• Finance cost declined 15% YoY to INR 51 million.
Chlorination,
Ammonolysis,
Hydrogenation, 48%
Valiant Organics Limited | Q1-2027 9
Key Chemistries
Chlorination (INR Mn) Hydrogenation (INR Mn) Ammonolysis (INR Mn) Others (INR Mn)
1,272
1,400 533 163
460 451 1,200 1,082 1,050 55 34 00 11 68 00 140
S E44 45 00 431 1,000 55 12 00 140
U430 120 94
800 500
N420 490 475
[Showing first 8,000 characters — download PDF for full document]